Table of Contents
Trinidad and Tobago has one of the highest hepatitis B infection rates in the Caribbean, and hepatitis C is an increasingly recognised concern, particularly among people who have injected drugs. Chronic hepatitis B and C are silent diseases – most people do not experience symptoms for years or even decades, during which time progressive liver damage, cirrhosis, and hepatocellular carcinoma are developing undetected. Early diagnosis through accessible Hepatitis B and C Rapid Test Kits is the most powerful intervention available to reduce the long- term liver disease burden in Trinidad and Tobago – and Jal Medical’s iCARE range provides exactly this capability.
Call Us Now!
The Hepatitis Burden in Trinidad and Tobago
Hepatitis B virus (HBV) infection is endemic in Trinidad and Tobago, with seroprevalence studies estimating infection rates of 3-6% in the general population – significantly above the global average. The country also has a significant population of people from South Asian and African backgrounds, ethnic groups that carry historically higher HBV prevalence globally. Hepatitis C (HCV) prevalence, while lower, has been documented among injection drug users, and is thought to be substantially underdiagnosed in the general population.
The consequences of undiagnosed chronic hepatitis are severe:
- Cirrhosis (liver scarring) develops in 15-25% of people with chronic HBV or HCV
- Liver cancer (hepatocellular carcinoma) risk is 100 times higher in people with chronic HBV
- Both infections are silent – most patients have no symptoms until late-stage liver disease
Early diagnosis enables life-saving antiviral treatment, regular monitoring, and vaccination of close contacts for hepatitis B— all of which can prevent disease progression and transmission.
iCARE Hepatitis B and C Rapid Test: What It Detects Jal Medical offers multiple hepatitis rapid test configurations for the Trinidad and Tobago
market:
HBsAg Rapid Screen Test – detects Hepatitis B Surface Antigen, the primary marker of active HBV infection. The iCARE HBsAg Rapid Test Kit is used globally for routine HBV screening in clinics, blood banks, and antenatal settings.
Hepatitis B Surface Antibody (HBsAb) Rapid Screen Test – detects immunity to HBV, whether from vaccination or past infection. Useful for checking vaccination status.
HBcAb Rapid Screen Test (Hepatitis core Antibody) – detects past or current HBV infection through the core antibody marker. The Hepatitis core Antibody Rapid Screen Test is a key tool for blood bank screening and epidemiological surveys.
Anti-HCV Rapid Screen / HCV Rapid Test Kit – detects antibodies to Hepatitis C virus, identifying individuals who have been exposed to HCV and require confirmatory testing.
Hepatitis B & C Combo Test – simultaneous HBsAg and HCV detection from a single sample, maximising screening efficiency.
Key product features:
- Whole blood, serum, or plasma sample types
- Results in 10-20 minutes
- Nolaboratory required Hep B Home Use Test Kit format for self-testing and pharmacy retail
- 1S0 13485:2016 and GMP certified manufacturing
Where These Tests Are Needed in Trinidad and Tobago
Hospitals and polyclinics: Port of Spain General Hospital, San Fernando General, and Eric Williams Medical Sciences Complex can integrate rapid hepatitis screening into emergency, pre- surgical, and outpatient workflows without laboratory delay.
Antenatal clinics: HBV screening in pregnancy is essential to enable hepatitis B immunoglobulin prophylaxis for newborns. Rapid point-of-care testing supports this in clinic and home delivery settings.
Blood banks and transfusion services: The HBsAg Rapid Screen Test and HBcAb Rapid Screen Test are used for donor blood screening where rapid turnaround is needed.
Harm reduction services: HCV testing among injection drug user communities – an identified risk population – can be integrated into existing harm reduction outreach using the Hep C Home Use Test Kit.
Pharmacy retail: Self-testing Hep B Home Test Kit formats support community awareness and enable individuals to know their hepatitis status privately.
Hepatitis B and C are preventable, treatable, and manageable – but only if diagnosed early. The iCARE Hepatitis B and C Rapid Test Kit from Jal Medical brings clinical-grade hepatitis diagnostics to every level of Trinidad and Tobago’s health system. As a leading Hepatitis B Test Kit manufacturer, HBsAg rapid test manufacturer, and HCV Test Kit supplier, Jal Medical is ready to supply bulk quantities to distributors, government health buyers, and hospital procurement teams in Trinidad and Tobago and across the Caribbean.
Get It Now!
